Global Isoflavones Market Set to Reach $1.5 Billion by 2025 - Comprehensive Industry Insights & OpportunitiesHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Global Isoflavones Market Set to Reach $1.5 Billion by 2025 - Comprehensive Industry Insights & OpportunitiesGlobeNewswireJanuary 2, 2020ReblogShareTweetShareDublin, Jan. 02, 2020 (GLOBE NEWSWIRE) -- The "Isoflavones Market by Source (Soy, Red Clover), Application (Pharmaceuticals, Nutraceuticals, Cosmetics, and Food & Beverages), Form (Powder and Liquid), and Region (North America, Europe, Asia Pacific, RoW) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.The global isoflavones market is estimated to be valued at USD 1.1 billion in 2019 and is likely to reach USD 1.5 billion by 2025, growing at a CAGR of 4.7% during the forecast period.Isoflavones are a phytoestrogen produced mainly by plants of the legume family, namely, soybeans, chickpeas, and red clover. They are potentially useful in lowering cholesterol, treating cancers and menopausal symptoms, maintain bone health, and so on. Growth in this market is mainly driven by the increasing incidences of chronic diseases, rising prevalence of cancer, technological advancements in the manufacturing of isoflavones, and the rapidly increasing geriatric population. However, stringent regulatory requirements and unfavourable drug price control policies across various countries are significant factors that are expected to restrain the growth of this market to a certain extent.The soy segment in isoflavones market is estimated to account for the largest share in 2019.Based on the source, the soy segment is estimated to account for the largest share in the isoflavones market in 2019. The segment is growing owing to factors such as nutritional and functional health-related properties since soy isoflavones are derived from soybeans and are particularly prevalent in soy germ. Genistein and daidzein are the major isoflavones present in soybean, which help in promoting overall health and wellness. The pharmaceuticals segment in the isoflavones market is estimated to account for the largest share in 2019.Based on the application, pharmaceuticals are estimated to account for the largest market share. The factors behind the growth is increasing the prevalence of diseases such as cancer, osteoporosis, and arthritis fuels the demand for isoflavones as they reduce the risk of the above-mentioned diseases and provide therapeutic effects. The North American isoflavones market is projected to witness significant growth.The North America region is projected to hold the major market share in the isoflavones market. It includes the US, Canada, Mexico. According to the United States Department of Agriculture, the US produced 341.62 million metric tons of soybean, Canada produced 7.72 million metric tons, and Mexico 0.43 million metric tons, in the year 2017-2018. The region is one of the leading producers of soybeans, which creates ample opportunities for the manufacturing of isoflavones. Another factor propelling the growth of isoflavones in the region is rising obesity, which is a major concern among the youth, which is directing consumer focus toward a healthy lifestyle, thereby promoting their overall health and wellness. Key Topics Covered 1 Introduction2 Research Methodology3 Executive Summary 4 Premium Insights 4.1 Attractive Opportunities in the Isoflavones Market4.2 Isoflavones Market, By Region4.3 Isoflavones Market, By Application4.4 Asia Pacific: Isoflavones Market, By Source and Country5 Market Overview 5.1 Introduction5.1.1 Drivers5.1.1.1 Rising Prevalence of Cancer and Cardiovascular Diseases5.1.1.2 Rapidly Increasing Geriatric Population5.1.1.3 Prevalence of Menopausal Issues5.1.1.4 Growth in Demand for Fortified Food Owing to the Increasing Health-Consciousness Amongst Consumers5.1.2 Restraints5.1.2.1 Stringent Regulatory Requirements5.1.3 Opportunities5.1.3.1 Emerging Markets5.1.3.2 Emerging Technologies5.1.4 Challenges5.1.4.1 Less Efficiency Compared to Alternatives5.2 Adjacent Economies - Market Size (Historical/Forecast)5.3 YC & YCC Shift6 Isoflavones Market, By Source 6.1 Introduction6.2 Soy6.2.1 Owing to the Nutritional and Functional Health-Related Properties, the Soy Segment is Projected to Dominate the Isoflavones Market6.3 Red Clover6.3.1 The Wide Applications of Red Clover in Applications Such as Food & Beverages, Pharmaceuticals, and Nutraceuticals to Drive the Demand6.4 Others7 Isoflavones Market, By Application 7.1 Introduction7.2 Pharmaceuticals7.3 Nutraceuticals7.4 Cosmetics7.5 Food & Beverages8 Isoflavones Market, By Form 8.1 Introduction8.2 Powder8.2.1 Owing to Factors Such as Convenience in Handling, Powdered Isoflavones in Pharmaceutical and Nutraceutical Industries to Witness High Demand8.3 Liquid8.3.1 Demand for Liquid Isoflavones From Cosmetic and Nutraceutical Industries to Fuel the Market9 Isoflavones Market, By Region 9.1 Introduction9.2 North America9.3 Europe9.4 Asia Pacific9.5 RoW10 Competitive Landscape 10.1 Overview10.2 Competitive Leadership Mapping (Overall Market)10.2.1 Terminology/Nomenclature10.2.1.1 Visionary Leaders10.2.1.2 Innovators10.2.1.3 Dynamic Differentiators10.2.1.4 Emerging Companies10.3 Ranking of Key Players, 201811 Company Profiles 11.1 Cargill11.2 ADM11.3 International Flavors and Fragrances (Frutarom)11.4 BASF11.5 DSM11.6 Nexira Inc.11.7 Shanghai Freemen11.8 SK Bioland11.9 Biomax11.1 Avestia Pharma11.11 Nutrascience Labs11.12 Tradichem S.L11.13 Nutra Green Biotechnology11.14 Herbo Nutra11.15 Futureceuticals Inc.11.16 Bio-Gen Extracts Pvt. Ltd11.17 Xena Bio Herbals Pvt Ltd.11.18 Sikko Industries Ltd.11.19 Shaanxi Hongda Phytochemistry Co. Ltd.11.20 Lactonova
For more information about this report visit https://www.researchandmarkets.com/r/b2ei9iStory continuesResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextDicerna Pharmaceuticals (DRNA) Reports Q4 Loss, Lags Revenue EstimatesZacks9 Must-See Spring Flower and Garden Festivals in the United StatesBetter Homes & GardensDollar Bond Market in Asia Gets Rougher for Virus-Hit BorrowersBloombergMarriott closes nearly a quarter of China hotels amid coronavirus concernsAmerican City Business JournalsSyros Pharmaceuticals, Inc. (SYRS) May Report Negative Earnings: Know the Trend Ahead of Q4 ReleaseZacksRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchMost face masks won’t protect you from the coronavirusYahoo FinanceStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinanceCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo Finance